APOBEC3B and esophageal squamous cell carcinoma: Previous studies have demonstrated that APOBEC3B can drive both tumor initiation and evolution in vivo.27 Importantly, the association of APOBEC signature activity with metastasis and poor prognosis in ESCC has been previously demonstrated,3 aligning with our findings (Supplementary Fig. 3c, d).